The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Recently added guidance documents regarding oncology and malignant hematology
Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses Part 2 of the DESTINY-Gastric03 trial (NCT04379596), which evaluated trastuzumab deruxtecan (T-DXd) with…
The OncoAlert Newsletter is now out for June 23-29, 2023
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
Ichiro Kinoshita, MD, PhD, Hokkaido University Hospital, Sapporo, Japan, discusses findings from the Phase II MYTHOS trial (jRCT2011210017), evaluating trastuzumab deruxtecan (T-DXd) in HER2-positive recurrent/metastatic…
FDA Broad Agency Announcement: Frequently Asked Questions for Oncology Researchers
CDC database analysis suggests that MDS-related mortality has declined since 2011, though significant disparities remain.
Cancer Statistical Fact Sheets are summaries of common cancer types developed to provide an overview of frequently-requested cancer statistics including incidence, mortality, survival, stage, prevalence,…
Pietro Lapidari, MD, Institut Gustave Roussy, Villejuif, France, explores the development of a predictive model for aromatase inhibitor musculoskeletal toxicity (AIMT) in postmenopausal patients with…
You could be our next great discovery. We’re searching for the brightest minds in cancer research. Applications for PhDs are open.
